Tag Archive | "Influenza"

CSL has acquired the Flu vaccine business from Novartis

Tags: , , ,


Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015. Read the full story

CSL: Partnering activity 2005-2013

Tags: , , ,


CSL is a global pharma company active in the development of vaccines and plasma proteins with a prime focus on influenza vaccine - partnering, collaborative R&D and licensing activity of CSL is reviewed here.

Read the full story

Vivaldi Biosciences biotech partners with Baxter for influenza vaccine assets

Tags: , , , ,


Vivaldi Biosciences has acquired from Baxter Healthcare research and development assets, including intellectual property, clinical data, know-how and materials, for LAIVs in which the gene for influenza nonstructural protein 1 has been fully deleted Read the full story

CureVac in pharma licensing deal with Janssen for influenza vaccine

Tags: , , , ,


CureVac has entered into a collaboration and pharma licensing agreement with Janssen Pharmaceuticals Read the full story

CSL Biotherapies makes pharma news with $1.5 billion award from US Government

Tags: , , ,


A popular headlines on the pharma news was CSL Biotherapies award of $1.5billion from the United States Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile
.

Read the full story

Influenza Partnering

Tags: , , ,


The Influenza Partnering provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story